GlyCardial Diagnostics is a spin-off company from the IR-Hospital de la Santa Creu i Sant Pau and the Spanish National Research Council (CSIC). The company is focused on the development of a novel in vitro diagnostic test for myocardial ischemia. The technology is based on the detection of Apo J-Glyc in blood as a biomarker for the early diagnosis of cardiac ischemia and the prediction of patient’s evolution after an ischemic event.

  • CEO & co-Founder: Dr. Judit Cubedo
  • CSO & co-Founder: Prof. Lina Badimon
  • Location: Barcelona
  • Website: